Wednesday, September 4, 2024
| 8:00 a.m. to 7:30 p.m. | Registration Desk Open |
| 7:30 a.m. to 8:30 a.m. | Continental Breakfast |
| 8:30 a.m. to 11:30 a.m. |
Workshop Qualitative Thinking and Best Practices in HTA: Unlocking Opportunities for Policy Impact Francesca Brundisini, Jamie Anne Bentz, and Elijiah Herrington, Canada’s Drug Agency |
| 8:30 a.m. to 11:30 a.m. |
Workshop Innovative Approaches to Real-World Evidence Generation: Selecting the Appropriate Study Design to Answer Your Evidence Needs Calum Neish, IQVIA Solutions Canada Inc. |
| 12:15 p.m. to 1:30 p.m. |
Special Session A New Era of Innovation and Collaboration in PMDE Tarry Ahuja, Canada’s Drug Agency |
| 12:15 p.m. to 3:15 p.m. |
Workshop Unlocking Ethics in HTA: Exploring Practice and Impact Renata Axler and Ana Komparic, Canada’s Drug Agency |
| 12:15 p.m. to 3:15 p.m. |
Workshop Gauging HTA Topic Importance and Potential Impact to Clinical Providers and Health Systems Johanna Anderson, Erin Beech, and Nicolas Parr, US Department of Veterans Affairs |
| 1:30 p.m. to 2:00 p.m. | Networking Break |
| 2:00 p.m. to 3:15 p.m. |
Special Session Drugs for Rare Diseases Nicole Mittmann, Trish Caetano, Canada’s Drug Agency |
| 3:30 p.m. to 4:45 p.m. |
Special Session Focus on Methods Farah Husein, Deirdre DeJean, and Renata Axler, Canada’s Drug Agency |
| 4:45 p.m. to 5:30 p.m. |
Student Meet and Greet Students attending the Symposium in person are invited to meet other student attendees and senior staff from Canada’s Drug Agency. A cash bar and light refreshments will be available. |
| 4:45 p.m. to 5:30 p.m. |
Patient Group Meet and Greet Representatives of patient groups attending the Symposium in person are invited to meet one another and senior staff from Canada’s Drug Agency. |
| 5:15 p.m. to 7:00 p.m. |
Welcome Reception and Scientific Poster Exhibition The Welcome Reception features scientific posters and the opportunity to meet and talk with the authors about their work. Recipients of the 2024 Recognition Awards will be presented. |
Thursday, September 5, 2024
| 7:30 a.m. to 5:30 p.m. | Registration Desk Open |
| 7:30 a.m. to 8:30 a.m. | Breakfast |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session Operationalizing Outcomes-Based Agreements in Canada Kate Harback, Institute of Health Economics |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session The Growing Problem of Drug Shortages: Understanding Their Impact on Research, Patients, and Healthcare Systems Mina Tadrous, University of Toronto; Stephanie Di Trapani, Health Canada; Saad Ahmed, University of Toronto |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session Embracing Healthcare Evolution: Using a Discrete Event Simulation Approach to Enhance Kidney Allocation Strategies Shahzad Ghanbarian, University of British Columbia |
| 8:45 a.m. to 9:30 a.m. | Official Opening Suzanne McGurn, President and CEO, Canada’s Drug Agency |
| 9:30 a.m. to 10:45 a.m. |
Opening Plenary
|
| 10:45 a.m. to 11:15 a.m. | Networking Break |
| 11:15 a.m. to 12:30 p.m. | Panel Session Innovation in the Pharmaceutical Ecosystem Sudha Kutty and Peter Dyrda, Canada’s Drug Agency |
| 11:15 a.m. to 12:30 p.m. | Panel Session Cultivating INDequity Through Indigenous-Led Pathways to eHealth Using an Innovative P3 Model to Partnership Vanessa Ambtman-Smith, Western University; Mehmood Alibhai, Boehringer Ingelheim Canada Ltd. |
| 11:15 a.m. to 12:30 p.m. | Panel Session Developing a Real-World Readiness Framework for Patient Support Programs: A Collaborative Approach Daniel Zimskind, ZS; Bryan Asher, Shoppers Drug Mart; Sarah Power, Takeda; Barry Stein, Colorectal Cancer Canada |
| 11:15 a.m. to 12:30 p.m. | Panel Session Incorporating the Child’s Perspective in Health Technology Assessment in Canada Jessie Elliot, Canada’s Drug Agency; Brittany Humphries, McMaster University; Wendy Ungar, Hospital for Sick Children Research Institute; Feng Xie, McMaster University |
| 11:15 a.m. to 12:30 p.m. | Panel Session Delivering Precision Oncology as Standard of Care: How Genomic Testing Is Driving Better Patient Outcomes and Increased Access to Clinical Trials for Cancer Patients Michael Carter and Tanya Gillian, Nova Scotia Health; Ravi Ramjeesingh, Dalhousie University |
| 12:30 p.m. to 1:30 p.m. | Networking Lunch |
| 1:30 p.m. to 2:45 p.m. | Oral Presentations Rare Disease Registries Building an Inventory of Rare Disease Registries in the Canadian Landscape Claudia Sikorski, Canada’s Drug Agency Developing Registry Standards Farah Husein, Canada’s Drug Agency Enhancing Data Quality and Infrastructure in Canadian Rare Disease Registries Viktoria Roman, Canada’s Drug Agency |
| 1:30 p.m. to 2:45 p.m. | Oral Presentations Oncology The Growing Importance of Companion Diagnostics on Cancer Therapeutics and Funding Scott Gavura, Ontario Health (Cancer Care Ontario) PROgress Tracker Breast Cancer Registry: Diverse Real-World Evidence to Inform HTA via a Patient Reported Outcomes Longitudinal Study of Canadian Breast Cancer Survivors Kimberly Carson and Shaniah Leduc, Breast Cancer Canada Patient Values Project: Understanding Patient Preferences for Cancer Treatments to Inform a Framework for Incorporating Patient Values Into Health Technology Assessment Deborah A Marshall, University of Calgary |
| 1:30 p.m. to 2:45 p.m. | Oral Presentations Hot Topics Partnering Together for Integrated Person- and Family-Centric Care Across the Mental Wellness Care Continuum: Stepped Care 2.0 in the Northwest Territories Danielle Impey, Mental Health Commission of Canada Navigating Growth: Ontario’s CAR T-Cell Therapy Program Cassandra McKay, Ontario Health (Cancer Care Ontario) Developing a Drug Shortages Predictive Model Using Real-World Canadian Drug Utilization Araniy Santhireswaran, University of Toronto Improving Equity Assessment in Drug Policy Decisions Jolanta Piszczek, University of British Columbia Therapeutic Value of Drugs for Orphan Diseases Joel Lexchin, York University |
| 1:30 p.m. to 2:45 p.m. | Oral Presentations Artificial Intelligence and Digital Health Homecare Innovations: At the Intersection of Technology and Humanity Corelia Kostovic and Marie-Helene Raymond, INESSS A National Standard for Cyber Resiliency in Healthcare Siri Chunduri and Jonathan I. Mitchell, HealthCareCAN Clinical Practice in a Digital Health Environment: New Best Practice Guideline Lauren Bailey, Registered Nurses’ Association of Ontario (RNAO) |
| 2:45 p.m. to 3:15 p.m. | Networking Break |
| 3:15 p.m. to 4:30 p.m. | Panel Session Disruptive Partnership: Charting the Future of pan-Canadian Data and Analytics Elena Lungu, Canada’s Drug Agency |
| 3:15 p.m. to 4:30 p.m. | Panel Session Breaking Barriers: Tackling Challenges in Mental Health Drug Health Technology Assessments Matthew Dick, IQVIA Solutions Canada Inc. (moderator); Don Husereau, IHE; Roger McIntyre, University of Toronto |
| 3:15 p.m. to 4:30 p.m. | Panel Session Rethinking How We Do HTA: Toward a Broader Health System Approach Leslie Anne Campbell, Dalhousie University; Craig Mitton, UBC; Laura Weeks, Canada’s Drug Agency |
| 3:15 p.m. to 4:30 p.m. | Panel Session Advancing Patient Engagement and Impact in CADTH’s Deliberative Process: A Multistakeholder Collaboration William Dempster, 3Sixty Public Affairs (Moderator); Gail Attara, Gastrointestinal Society; Bonnie Macfarlane, Janssen Inc.; Heather Logan, Canada’s Drug Agency; Jessy Ranger, Myeloma Canada; Nancy Zorzi, Mood Disorders Society of Canada |
| 5:30 p.m. to 9:00 p.m. | Social Event |
Friday, September 6, 2024
| 7:30 a.m. to 3:00 p.m. | Registraion Desk Open |
| 7:30 a.m. to 8:45 a.m. | Breakfast |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session Real-World Evidence (RWE): Empowering Patient Advocacy Groups to Co-Design Registries That Fill a Data Gap for Their Community Kyle Fitzgerald, Alzheimer Society of Ontario, Christa Studzinski, Ontario Brain Institute |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session Tackling Environmental Impacts in Healthcare Systems and in Health Technology Assessment Agencies Towards 2030: Where Do We Stand With 6 Years Left? Corelia Kostovic, INESSS |
| 7:45 a.m. to 8:30 a.m. | Early Morning Session What’s New in US HTA? A Snapshot of ICER’s Value Assessment Framework Update Daniel Ollendorf and Marina Richardson, Institute for Clinical and Economic Review (ICER) |
| 8:45 a.m. to 10:00 a.m. | Panel Session Closing the Gap or Widening the Divide: Do We Need a Framework for Truly Embedding Equity in Health Technology Assessment (HTA)? Jonathan Pearson-Stuttard, Lane Clark & Peacock LLP (Moderator), Stephen Duffield, National Institute for Health and Care Excellence; Susan Griffin, University of York; Chris Lubker, Novo Nordisk; Marina Richardson, Institute for Clinical and Economic Review |
| 8:45 a.m. to 10:00 a.m. | Panel Session Appropriate Use Sudha Kutty, Canada’s Drug Agency |
| 8:45 a.m. to 10:00 a.m. | Panel Sessions An Innovative and Learning Health System Fueled by Digital and Technological Transformation: Recent Successes From the Nova Scotia Health Cancer Care Program Amanda Caissie, Helmut Hollenhorst, and Gail Tomblin Murphy, Nova Scotia Health |
| 8:45 a.m. to 10:00 a.m. | Panel Sessions From Disruption to Opportunity: What Can HTA Learn from Taylor Swift? Nancy Sikich, Sarah McDowell, Chunmei Li, and Olga Gajic-Veljanoski, Ontario Health |
| 10:00 a.m. to 10:30 a.m. | Networking Break |
| 10:30 a.m. to 11:30 a.m. | Oral Presentations Diverse Perspectives Prioritizing Community Partnerships: A Collaborative Approach to Promoting Medication Appropriateness Across Diverse B.C. Communities Leslie Gaudette, Council of Senior Citizens’ Organizations of British Columbia Advancing Justice-Oriented Patient Engagement in Health Technology Assessment Roma Dhamanaskar, McMaster University Public Preferences for Improving Health Equity in Canada: A Qualitative Focus Group Study Christopher Cadham, University of Michigan |
| 10:30 a.m. to 11:30 a.m. | Oral Presentations Maximizing the Impact of HTA Improving the Impact of Health Technology Assessment (HTA) in Canada Craig Mitton, University of British Columbia An Actionable and Legible Toolbox for the Appraisal of Healthcare Innovations Developed Through Provincial Stakeholder Collaboration Pascale Lehoux, INESSS |
| 10:30 a.m. to 11:30 a.m. | Oral Presentations HTA Methods Quantitative Assessment of Effect Modifiers in NMA: Leveraging Subgroup Data Timothy Disher, CRG-EVERSANA Humanizing HTA Practices: The INESSS Users’ and Relatives’ Panel Louis Lochhead and Marie-Pascale Pomey, INESSS Understanding and Measuring Health Outcomes in Children With Rare Genetic Conditions Jeff Round, Institute of Health Economics |
| 10:30 a.m. to 11:30 a.m. | Oral Presentations Health Economics Model-Based Estimates of the Cost of Obstetric Evacuation for Fly-In First Nation Communities in Ontario Majd Radhaa, Western University Identifying High-Cost Users in Ontario: Implications of Follow-Up Time and Censoring for Measuring High-Cost Users Using Administrative Data Kali Barrett, University of Toronto Integrating Lived Experience: Developing a Theoretical and Methodological Approach to Conducting an Institutional Ethnography for Economic Evaluations Chantal Valiquette, University of Toronto 23 and (Not Just) Me: Incorporating Family Members in Economic Evaluation of Genetic Testing Technologies Wendy Ungar, Technology Assessment at SickKids (TASK), Hospital for Sick Children Research Institute |
| 10:30 a.m. to 11:30 a.m. | Oral Presentations Medical Devices Level 2 Polysomnography for the Diagnosis of Sleep Disorders: A Health Technology Assessment Samrawit Lemma, Stacey Vandersluis, Nancy Sikich, Ontario Health (OH) The Canadian Medical Imaging Inventory (CMII): A Decade of Difference Andra Morrison, Canada’s Drug Agency |
| 11:30 a.m. to 12:00 p.m. | Networking Break |
| 12:00 p.m. to 1:15 p.m. |
Closing Plenary
|
| 1:15 p.m. to 1:30 p.m. | Presentation of the Student Poster Award and Official Closing Suzanne McGurn, President and CEO, Canada’s Drug Agency |
| 1:30 p.m. to 2:30 p.m. | Closing Reception Join us for the grand finale of Symposium 2024 at the closing reception! Unwind and network with fellow attendees. Celebrate the culmination of insightful discussions and fruitful connections in a relaxed and inviting atmosphere. Don't miss this opportunity to toast the success of another memorable Symposium experience! Delectable appetizers and a cash bar will be available. |